Mostrar registro simples

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

dc.contributor.authorReis Neto, Edgard Torres dospt_BR
dc.contributor.authorKakehasi, Adriana Mariapt_BR
dc.contributor.authorPinheiro, Marcelo de Medeirospt_BR
dc.contributor.authorFerreira, Gilda Aparecidapt_BR
dc.contributor.authorMarques, Cláudia Diniz Lopespt_BR
dc.contributor.authorMota, Licia Maria Henrique dapt_BR
dc.contributor.authorPaiva, Eduardo dos Santospt_BR
dc.contributor.authorPileggi, Gecilmara Cristina Salviatopt_BR
dc.contributor.authorSato, Emilia Inouept_BR
dc.contributor.authorReis, Ana Paula Monteiro Gomidespt_BR
dc.contributor.authorXavier, Ricardo Machadopt_BR
dc.contributor.authorProvenza, José Robertopt_BR
dc.date.accessioned2021-09-01T04:25:52Zpt_BR
dc.date.issued2020pt_BR
dc.identifier.issn2523-3106pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/229323pt_BR
dc.description.abstractHydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-mediated inflammatory rheumatic diseases for decades. It is an appropriate time to review their immunomodulatory and anti-inflammatory mechanisms impact on disease activity and survival of systemic lupus erythematosus patient, including antiplatelet effect, metabolic and lipid benefits. We also discuss possible adverse effects, adding a practical and comprehensive approach to monitoring rheumatic patients during treatment with these drugs.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofAdvances in rheumatology. São Paulo. Vol. 60 (2020), 32, 11 p.pt_BR
dc.rightsOpen Accessen
dc.subjectDoenças reumáticaspt_BR
dc.subjectHydroxychloroquineen
dc.subjectChloroquineen
dc.subjectDoença crônicapt_BR
dc.subjectAntimalarialsen
dc.subjectInflamaçãopt_BR
dc.subjectCloroquinapt_BR
dc.subjectChronic immune-mediated inflammatory rheumatic diseasesen
dc.subjectHidroxicloroquinapt_BR
dc.titleRevisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseasespt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001130599pt_BR
dc.type.originNacionalpt_BR


Thumbnail
Nome:
001130599.pdf
Tamanho:
1.767Mb
Formato:
PDF
Descrição:
Texto completo (inglês)
Visualizar/abrir
   

Este item está licenciado na Creative Commons License

Mostrar registro simples